These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
265 related articles for article (PubMed ID: 20470188)
1. Emerging drugs for the treatment of symptoms associated with autism spectrum disorders. Wink LK; Plawecki MH; Erickson CA; Stigler KA; McDougle CJ Expert Opin Emerg Drugs; 2010 Sep; 15(3):481-94. PubMed ID: 20470188 [TBL] [Abstract][Full Text] [Related]
2. Pharmacotherapy to control behavioral symptoms in children with autism. Doyle CA; McDougle CJ Expert Opin Pharmacother; 2012 Aug; 13(11):1615-29. PubMed ID: 22550944 [TBL] [Abstract][Full Text] [Related]
3. Pharmacologic treatment of behavioral symptoms associated with autism and other pervasive developmental disorders. Wink LK; Erickson CA; McDougle CJ Curr Treat Options Neurol; 2010 Nov; 12(6):529-38. PubMed ID: 20848330 [TBL] [Abstract][Full Text] [Related]
4. Yokukansan (TJ-54) for irritability associated with pervasive developmental disorder in children and adolescents: a 12-week prospective, open-label study. Wake R; Miyaoka T; Inagaki T; Furuya M; Ieda M; Liaury K; Kishi K; Horiguchi J J Child Adolesc Psychopharmacol; 2013 Jun; 23(5):329-36. PubMed ID: 23782127 [TBL] [Abstract][Full Text] [Related]
10. Analysis of Copper and Zinc Plasma Concentration and the Efficacy of Zinc Therapy in Individuals with Asperger's Syndrome, Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS) and Autism. Russo AJ; Devito R Biomark Insights; 2011; 6():127-33. PubMed ID: 22174567 [TBL] [Abstract][Full Text] [Related]
11. A naturalistic open-label study of mirtazapine in autistic and other pervasive developmental disorders. Posey DJ; Guenin KD; Kohn AE; Swiezy NB; McDougle CJ J Child Adolesc Psychopharmacol; 2001; 11(3):267-77. PubMed ID: 11642476 [TBL] [Abstract][Full Text] [Related]
12. Redefining autism spectrum disorder using DSM-5: the implications of the proposed DSM-5 criteria for autism spectrum disorders. Young RL; Rodi ML J Autism Dev Disord; 2014 Apr; 44(4):758-65. PubMed ID: 24057130 [TBL] [Abstract][Full Text] [Related]
14. The incidence and prevalence of pervasive developmental disorders: a Danish population-based study. Lauritsen MB; Pedersen CB; Mortensen PB Psychol Med; 2004 Oct; 34(7):1339-46. PubMed ID: 15697060 [TBL] [Abstract][Full Text] [Related]
15. Prevalence of autism spectrum disorders--Autism and Developmental Disabilities Monitoring Network, 14 sites, United States, 2008. ; MMWR Surveill Summ; 2012 Mar; 61(3):1-19. PubMed ID: 22456193 [TBL] [Abstract][Full Text] [Related]
16. Application of DSM-5 criteria for autism spectrum disorder to three samples of children with DSM-IV diagnoses of pervasive developmental disorders. Huerta M; Bishop SL; Duncan A; Hus V; Lord C Am J Psychiatry; 2012 Oct; 169(10):1056-64. PubMed ID: 23032385 [TBL] [Abstract][Full Text] [Related]
17. [Pharmacological treatments in patients with pervasive developmental disorders: A review]. Béhérec L; Quilici G; Rosier A; Gerardin P; Campion D; Guillin O Encephale; 2014 Apr; 40(2):188-96. PubMed ID: 24369879 [TBL] [Abstract][Full Text] [Related]
18. Higher-functioning pervasive developmental disorders: rates and patterns of psychotropic drug use. Martin A; Scahill L; Klin A; Volkmar FR J Am Acad Child Adolesc Psychiatry; 1999 Jul; 38(7):923-31. PubMed ID: 10405512 [TBL] [Abstract][Full Text] [Related]
19. [Gender dysphoria in pervasive developmental disorders]. Tateno M; Ikeda H; Saito T Seishin Shinkeigaku Zasshi; 2011; 113(12):1173-83. PubMed ID: 22352003 [TBL] [Abstract][Full Text] [Related]
20. The genetics of autism. Muhle R; Trentacoste SV; Rapin I Pediatrics; 2004 May; 113(5):e472-86. PubMed ID: 15121991 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]